Cutting Edge: Hypoxia-Inducible Factor 1α and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes

Dmitriy Lukashev(Northeastern University), Boris Klebanov(Northeastern University), Hidefumi Kojima(Dokkyo University), Alex Grinberg(National Institutes of Health), Akiko Ohta(Northeastern University), Ludmilla Berenfeld(Northeastern University), Roland H. Wenger(University of Zurich), Akio Ohta(Northeastern University), Michail V. Sitkovsky(Northeastern University)
The Journal of Immunology
October 1, 2006
Cited by 206

Abstract

To evaluate the role of hypoxia-inducible factor 1alpha (HIF-1alpha) and its TCR activation-inducible short isoform I.1 in T cell functions, we genetically engineered unique mice with: 1) knockout of I.1 isoform of HIF-1alpha; 2) T cell-targeted HIF-1alpha knockdown; and 3) chimeric mice with HIF-1alpha gene deletion in T and B lymphocytes. In all three types of mice, the HIF-1alpha-deficient T lymphocytes, which were TCR-activated in vitro, produced more proinflammatory cytokines compared with HIF-1alpha-expressing control T cells. Surprisingly, deletion of the I.1 isoform, which represents < 30% of total HIF-1alpha mRNA in activated T cells, was sufficient to markedly enhance TCR-triggered cytokine secretion. These data suggest that HIF-1alpha not only plays a critical role in oxygen homeostasis but also may serve as a negative regulator of T cells.


Related Papers

No related papers found

Powered by citation graph analysis